- Home
- PLMK vs NYXH Comparison
PLMK vs NYXH Comparison
Compare PLMK & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMK
- NYXH
- Stock Information
- Founded
- PLMK 2024
- NYXH 2009
- Country
- PLMK United States
- NYXH Belgium
- Employees
- PLMK N/A
- NYXH N/A
- Industry
- PLMK
- NYXH Medical/Dental Instruments
- Sector
- PLMK
- NYXH Health Care
- Exchange
- PLMK NYSE
- NYXH Nasdaq
- Market Cap
- PLMK 241.7M
- NYXH 222.3M
- IPO Year
- PLMK 2025
- NYXH 2021
- Fundamental
- Price
- PLMK $10.18
- NYXH $7.58
- Analyst Decision
- PLMK
- NYXH Strong Buy
- Analyst Count
- PLMK 0
- NYXH 4
- Target Price
- PLMK N/A
- NYXH $14.50
- AVG Volume (30 Days)
- PLMK 6.3K
- NYXH 144.1K
- Earning Date
- PLMK 01-01-0001
- NYXH 05-14-2025
- Dividend Yield
- PLMK N/A
- NYXH N/A
- EPS Growth
- PLMK N/A
- NYXH N/A
- EPS
- PLMK N/A
- NYXH N/A
- Revenue
- PLMK N/A
- NYXH $4,716,818.00
- Revenue This Year
- PLMK N/A
- NYXH $323.07
- Revenue Next Year
- PLMK N/A
- NYXH $204.30
- P/E Ratio
- PLMK N/A
- NYXH N/A
- Revenue Growth
- PLMK N/A
- NYXH N/A
- 52 Week Low
- PLMK $9.94
- NYXH $5.55
- 52 Week High
- PLMK $10.21
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- PLMK N/A
- NYXH 57.85
- Support Level
- PLMK N/A
- NYXH $7.52
- Resistance Level
- PLMK N/A
- NYXH $8.00
- Average True Range (ATR)
- PLMK 0.00
- NYXH 0.47
- MACD
- PLMK 0.00
- NYXH 0.09
- Stochastic Oscillator
- PLMK 0.00
- NYXH 63.95
About PLMK PLUM ACQUISITION CORP IV
Plum Acquisition Corp IV is a blank check company.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.